The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study
conference contribution
posted on 2019-05-01, 00:00authored byDale Bailey, David Chan, Paul Roach, Geoffrey Schembri, Elizabeth Bernard, Edward Hsiao, Aimee Hayes, Mustafa Khasraw, Jaswinda Samra, Nick Pavlakis
The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study